Kidney Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Kidney Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Nov 08, 2018

---

• Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.  
  Zhou Liang et al. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2018 Sep 1051155-1163
• Imaging findings of hereditary renal tumors, a review of what the radiologist should know.  
  Czarniecki Marcin et al. European journal of radiology 2018 Apr 1018-16
• Imaging for Screening and Surveillance of Patients with Hereditary Forms of Renal Cell Carcinoma.  
  Freifeld Yuval et al. Current urology reports 2018 Aug 19(10) 82
• Recommendations for the Management of Rare Kidney Cancers.  
  Giles Rachel H et al. European urology 2017 72(6) 974-983
• Renal cell cancer linked to Lynch syndrome: Increased incidence and loss of mismatch repair protein expression.  
  Therkildsen Christina et al. International journal of urology : official journal of the Japanese Urological Association 2016 23(6) 528-9
• Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers.  
  Li Qing Kay et al. Seminars in cancer biology 2018 Jul
• Broadening the View of Germline Mutations in Kidney Cancer.  
  Pilié Patrick G et al. JAMA oncology 2018 Jul
• Clinical utility of the S3-score for molecular prediction of outcome in non-metastatic and metastatic clear cell renal cell carcinoma.  
  Büttner Florian et al. BMC medicine 2018 Jul 16(1) 108
• Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma  
  MI Carlo et al, JAMA Oncology, July 5, 2018
• Applying Precision Oncology to Renal Cell Carcinoma: Emerging Challenges.  
  Leppert John T et al. European urology 2017 72(4) 565-566